In addition to a planned $225 million investment in a Cincinnati facility to increase the site’s drug product capacity, Resilience plans to expand its drug product capabilities at the company’s Research Triangle Park facility using a modular design within its segregated expansion space to offer drug product manufacturing for multiple modalities, the company said.
Read MoreThough JLL has produced a life sciences industry report for years, this is the first one that has broken out the important biomanufacturing segment.
Read More
A new program, NC BioBetter, aims to support students and maximize positive impact on developing a right-skilled biotechnology workforce in North Carolina.
Read More
President Joe Biden is launching a new initiative to encourage biotech production and research in the U.S., the latest move by the White House to boost domestic industry. North Carolina is a source for much biomanufacturing.
Read More
The U.S. subsidiary of a German-based company is seeking a facility in the Triangle to manufacture its leading product, used to close perforations and stop bleeding in the GI tract during a patient’s endoscopy, and anticipates hiring additional employees in the region.
Read More
The life science cluster in Raleigh-Durham is ranked fifth in the nation, making the Triangle an appealing and profitable place for industry businesses and related real estate.
Read More
A new 5-year project led by North Carolina State University will sponsor an international collaborative research and training program in biomanufacturing science and technology.
Read More
A significant new arrow has just been added to the quiver of North Carolina’s biomanufacturing global leadership arsenal.
Read More
The 25th annual life science and technology conference in Raleigh will focus on cutting-edge technologies designed to improve the delivery of drugs to patients with life-threatening illnesses.
Read More
